Favourable effect of combined Miscleron-Xavin treatment on HDL-cholesterol level. 1983

G Pados, and D Kusztos, and M Németh-Csóka, and M Valyon, and K Farkas

UI MeSH Term Description Entries
D006951 Hyperlipoproteinemias Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation. Hyperlipoproteinemia
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013806 Theophylline A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. 1,3-Dimethylxanthine,3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione,Accurbron,Aerobin,Aerolate,Afonilum Retard,Aquaphyllin,Armophylline,Bronchoparat,Bronkodyl,Constant-T,Elixophyllin,Euphylong,Glycine Theophyllinate,Lodrane,Monospan,Nuelin,Nuelin S.A.,Quibron T-SR,Slo-Phyllin,Somophyllin-T,Sustaire,Synophylate,Theo Von Ct,Theo-24,Theo-Dur,Theobid,Theocin,Theoconfin Continuous,Theodur,Theolair,Theolix,Theon,Theonite,Theopek,Theophylline Anhydrous,Theophylline Sodium Glycinate,Theospan,Theostat,Theovent,Uniphyl,Uniphyllin,Uniphylline,1,3 Dimethylxanthine,Anhydrous, Theophylline,Constant T,ConstantT,Ct, Theo Von,Glycinate, Theophylline Sodium,Quibron T SR,Quibron TSR,Slo Phyllin,SloPhyllin,Sodium Glycinate, Theophylline,Somophyllin T,SomophyllinT,Theo 24,Theo Dur,Theo24,Theophyllinate, Glycine,Von Ct, Theo
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride
D014971 Xanthinol Niacinate A vasodilator used in peripheral vascular disorders and insufficiency. It may cause gastric discomfort and hypotension. Xanthinol Nicotinate,Xantinol Nicotinate,Complamin,Complamine,Komplamin,Sadamin,Sadamine,Teonicol,Xantinol-nicotinat-ratiopharm,Xavin,Niacinate, Xanthinol,Nicotinate, Xanthinol,Nicotinate, Xantinol

Related Publications

G Pados, and D Kusztos, and M Németh-Csóka, and M Valyon, and K Farkas
August 1979, Acta medica Okayama,
G Pados, and D Kusztos, and M Németh-Csóka, and M Valyon, and K Farkas
January 2003, Journal of Ayub Medical College, Abbottabad : JAMC,
G Pados, and D Kusztos, and M Németh-Csóka, and M Valyon, and K Farkas
January 2006, Medicinski arhiv,
G Pados, and D Kusztos, and M Németh-Csóka, and M Valyon, and K Farkas
December 1990, JAMA,
G Pados, and D Kusztos, and M Németh-Csóka, and M Valyon, and K Farkas
January 1983, Dakar medical,
G Pados, and D Kusztos, and M Németh-Csóka, and M Valyon, and K Farkas
January 1971, Therapia Hungarica (English edition),
G Pados, and D Kusztos, and M Németh-Csóka, and M Valyon, and K Farkas
July 1979, Circulation,
G Pados, and D Kusztos, and M Németh-Csóka, and M Valyon, and K Farkas
February 1982, Clinical chemistry,
G Pados, and D Kusztos, and M Németh-Csóka, and M Valyon, and K Farkas
November 1978, British medical journal,
G Pados, and D Kusztos, and M Németh-Csóka, and M Valyon, and K Farkas
May 1986, Pneumonologia polska,
Copied contents to your clipboard!